OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autoantibody screening in Guillain–Barré syndrome
Cinta Lleixà, L. Aguilar, Elba Pascual‐Goñi, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Guillain-Barré syndrome: expanding the concept of molecular mimicry
Jon D. Laman, Ruth Huizinga, Geert‐Jan Boons, et al.
Trends in Immunology (2022) Vol. 43, Iss. 4, pp. 296-308
Open Access | Times Cited: 52

Antibodies in Autoimmune Neuropathies
Elba Pascual‐Goñi, Marta Caballero‐Ávila, Luís Querol
Neurology (2024) Vol. 103, Iss. 4
Open Access | Times Cited: 9

B lymphocytes in COVID-19: a tale of harmony and discordance
Amir Hossein Mansourabadi, Azin Aghamajidi, Maryam Dorfaki, et al.
Archives of Virology (2023) Vol. 168, Iss. 5
Open Access | Times Cited: 20

Guillain‐Barré syndrome: History, pathogenesis, treatment, and future directions
Richard AC Hughes
European Journal of Neurology (2024) Vol. 31, Iss. 11
Open Access | Times Cited: 6

Guillain–Barré syndrome
Sonja E. Leonhard, Nowshin Papri, Luís Querol, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 6

COVID‐19 as a trigger of Guillain‐Barré syndrome: A review of the molecular mechanism
Mahdi Malekpour, Shaghayegh Khanmohammadi, Mohammad Javad Entezari Meybodi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 14

Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology
Marta Caballero‐Ávila, Cinta Lleixà, Elba Pascual‐Goñi, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 4

Peripheral neuropathies
Michael P. Lunn, Helmar C. Lehmann, Kazim A. Sheikh
Elsevier eBooks (2024), pp. 1645-1665
Closed Access | Times Cited: 4

A Rare Guillain-Barré Syndrome Variant with Multi-Ganglioside Reactivity: A Case of Severe Cranial Nerve Involvement
Laura Gómez‐Dabo, Arnau Llauradó, Daniel Sánchez‐Tejerina, et al.
Revista de Neurología (2025) Vol. 80, Iss. 1
Closed Access

Campylobacter jejuni Infection, Anti-Ganglioside Antibodies, and Neuropathy
Norman Latov
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2139-2139
Open Access | Times Cited: 18

Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies
Roger Collet, Marta Caballero‐Ávila, Luís Querol
Revue Neurologique (2023) Vol. 179, Iss. 8, pp. 831-843
Closed Access | Times Cited: 9

Antiganglioside antibody frequency in routine clinical care settings
Niklas Giesche, Samuel Tobias Böhm‐Gonzalez, Benedict Kleiser, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 7
Open Access | Times Cited: 3

Ultrasensitive assay technology and fluid biomarkers for the evaluation of peripheral nerve disease
Roberto Bellanti, Stephen Keddie, Michael P. Lunn, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 95, Iss. 2, pp. 114-124
Open Access | Times Cited: 6

The Neurological Implications of COVID-19: A Comprehensive Narrative Review
Ithamar Cheyne, Venmanassery Sreejan Gopinath, Neeharika Muppa, et al.
Cureus (2024)
Open Access | Times Cited: 2

Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies
Alexander J. Davies, Cinta Lleixà, Ana M. Siles, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 10

mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis
Yolanda Blanco, Domingo Escudero, Cinta Lleixà, et al.
Neurology Neuroimmunology & Neuroinflammation (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 6

Distribution characteristics of antinuclear antibodies in Guillain-Barré syndrome and its relationship with disease severity
Lingxin Kong, Juan Wang, Xiujuan Wu, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 244, pp. 108421-108421
Closed Access | Times Cited: 1

Expanding our understanding of Guillain–Barré syndrome: Recent advances and clinical implications
Paolo Ripellino, Bettina Schreiner, Daniela Latorre
European Journal of Immunology (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 1

Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection
Juan Luis Restrepo‐Vera, Arnau Llauradó, Antoni Palasí, et al.
Acta Neurologica Scandinavica (2023) Vol. 2023, pp. 1-9
Open Access | Times Cited: 3

Impact of Antecedent Infections on the Antibodies against Gangliosides and Ganglioside Complexes in Guillain-Barré Syndrome
Debprasad Dutta, Monojit Debnath, Doniparthi V. Seshagiri, et al.
Annals of Indian Academy of Neurology (2022) Vol. 25, Iss. 3, pp. 401-406
Open Access | Times Cited: 5

Campylobacter jejuni and Postinfectious Autoimmune Diseases: A Proof of Concept in Glycobiology
Richard A. Stein
ACS Infectious Diseases (2022) Vol. 8, Iss. 10, pp. 1981-1991
Closed Access | Times Cited: 5

Atypical Guillain-Barré syndrome with positive anti-sulfatide, anti-GT1b, and anti-GT1a antibodies: A case report
Fei-Fei Tan, H Liu, Xueyan Huang, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 20, pp. 4372-4376
Open Access

Perfil clínico de pacientes com Síndrome de Guillain Barré em um hospital de Santa Catarina
Pedro Henrique Rocha Zin, Jucélia Jeremias Fortunato
Revista Neurociências (2024) Vol. 32, pp. 1-30
Open Access

Page 1 - Next Page

Scroll to top